Skip to main content

Table 3 Pathological characteristics

From: Efficacy and safety of preoperative 5-fluorouracil, cisplatin, and mitomycin C in combination with radiotherapy in patients with resectable and borderline resectable pancreatic cancer: a long-term follow-up study

Characteristic Patients (n = 17)
Histology (PDAC), n (%) 17 (100.0)
T stage, n (%)
 T0 0 (0.0)
 Tis 0 (0.0)
 T1 4 (23.5)
 T2 1 (5.9)
 T3 12 (70.6)
N stage, n (%)
 N0 12 (70.6)
 N1 5 (29.4)
TNM stage, n (%)
 0 0 (0.0)
 IA 3 (17.6)
 IB 1 (5.9)
 IIA 8 (47.1)
 IIB 5 (29.4)
Negative microscopic resection margins, n (%)
 R0 16 (94.1)
 R1 1 (5.9)
Differentiation, n (%)
 Well-moderate 6 (35.3)
 Moderate-poor 10 (58.8)
 Other 1 (5.9)
Portal vein invasion status, n (%) 2 (11.8)
Microscopic lymphovascular invasion, n (%) 8 (47.1)
Microscopic perineural invasion, n (%) 5 (29.4)
Evans’ classification, n (%)
 I 0 (0.0)
 IIA 10 (58.8)
 IIB 5 (29.4)
 III 0 (0.0)
 IV 2 (11.8)
  1. Abbreviations: PDAC pancreatic ductal adenocarcinoma, TNM tumor-node-metastasis